Related content

Androgen receptor as a target for the treatment of hormone receptor-negative breast cancer: an unchartered territory

By Nahleh Zeina  

Future Oncology, Vol. 4, Iss. 1, 2008-02 ,pp. : 15-21

Future Medicine

Access to resources Recommend Favorite

Lower Level of MAPK Expression Is Associated with Anthracycline Resistance and Decreased Survival in Patients with Hormone Receptor Negative Breast Cancer

By Derin Duygu   Eralp Yesim   Ozluk Yasemin   Yavuz Ekrem   Guney Nese   Saip Pinar   Igci Abdullah   Ozmen Vahit   Kucucuk Seden   Aslay Isik   Aydiner Adnan   Topuz Erkan  

Cancer Investigation, Vol. 26, Iss. 7, 2008-08 ,pp. : 671-679

Informa Healthcare

Access to resources Recommend Favorite

Health-Related Quality of Life in Axillary Node-Negative, Estrogen Receptor-Negative Breast Cancer Patients Undergoing AC Versus CMF Chemotherapy: Findings from the National Surgical Adjuvant Breast and Bowel Project B-23

By Land Stephanie   Kopec Jacek   Yothers Greg   Anderson Stewart   Day Richard   Tang Gong   Ganz Patricia   Fisher Bernard   Wolmark Norman  

Breast Cancer Research and Treatment, Vol. 86, Iss. 2, 2004-07 ,pp. : 153-164

Springer Publishing Company

Access to resources Recommend Favorite

Effects of obesity and race on prognosis in lymph node-negative, estrogen receptor-negative breast cancer

By Dignam James   Wieand Kelly   Johnson Karen   Raich Peter   Anderson Stewart   Somkin Carol   Wickerham D.  

Breast Cancer Research and Treatment, Vol. 97, Iss. 3, 2006-06 ,pp. : 245-254

Springer Publishing Company

Access to resources Recommend Favorite

Microarray phosphatome profiling of breast cancer patients unveils a complex phosphatase regulatory role of the MAPK and PI3K pathways in estrogen receptor-negative breast cancers

By  

International Journal of Oncology, Vol. 45, Iss. 6, 2014-01 ,pp. : 2250-2266

Spandidos Publications

Access to resources Recommend Favorite